河南羚锐制药股份有限公司关于大股东部分股份解除质押的公告

Core Viewpoint - The announcement details the release of share pledges by the major shareholder, Henan Lingrui Group Co., Ltd., and outlines the current status of share pledges related to Henan Lingrui Pharmaceutical Co., Ltd. [1][2] Group 1: Major Shareholder's Share Pledge Release - Lingrui Group holds 121,817,898 shares of the company, accounting for 21.48% of the total share capital. After the release of the pledge, the total number of pledged shares is 28,350,000, which represents 23.27% of Lingrui Group's holdings and 5.00% of the company's total share capital [2][3] - There are no plans for further pledges of the released shares. The company will fulfill its information disclosure obligations in accordance with relevant laws and regulations if any new pledging occurs [3] Group 2: Current Pledge Situation of Major Shareholder and Associates - As of the announcement date, Lingrui Group and its concerted parties have a total of 28,350,000 pledged shares, which is 22.18% of their combined holdings and 5.00% of the company's total share capital [2][4] - The company will continue to monitor the pledge situation and associated risks of the major shareholder and its concerted parties, ensuring timely information disclosure as required [4]